OTC COUGH/COLD PREPS GIVEN TO MORE THAN ONE-THIRD OF THREE YEAR-OLDS
This article was originally published in The Tan Sheet
OTC COUGH/COLD PREPS GIVEN TO MORE THAN ONE-THIRD OF THREE YEAR-OLDS in a study of OTC drug use in young children published in the Oct. 5 issue of the Journal of the American Medical Association. The study, conducted by Michael Kogan, PhD, et al. National Center for Health Statistics of the Centers for Disease Control and Prevention, found that 35.4% of a sample of 8,145 children were reported to have been given a cough/cold preparation in the previous 30 days. The study was based on interviews with the children's mothers.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC